Improvement of platelet dysfunction in chronic myelogenous leukemia following treatment with imatinib: a case report

INTRODUCTION: In patients with chronic myeloid leukemia, tyrosine kinase inhibitors suppress the BCR-ABL(+ )clone and often induce complete molecular remissions. Megakaryocytes in such patients have been shown to be derived from the BCR-ABL(+ )clone, and abnormal platelet function is frequent in chr...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Shimabukuro-Vornhagen, Alexander, Rothe, Achim, Nogova, Lucia, Kochanek, Matthias, Scheid, Christoph, von Bergwelt-Baildon, Michael
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117828/
https://ncbi.nlm.nih.gov/pubmed/21624109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-5-215
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky